2009
DOI: 10.1097/ccm.0b013e3181959814
|View full text |Cite
|
Sign up to set email alerts
|

Phosphodiesterase 2 inhibition diminished acute lung injury in murine pneumococcal pneumonia*

Abstract: PDE2 inhibition diminished microvascular leakage in pneumococcal pneumonia, and pulmonary PDE2 upregulation may play a crucial role in this respect. Selective PDE2 inhibitors thus may offer a promising therapeutic approach in severe pneumococcal pneumonia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

3
20
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 39 publications
3
20
0
Order By: Relevance
“…These results serve to confirm the emerging idea that PDE2A is a key proinflammatory enzyme that enhances the cellular and humoral inflammation associated with common forms of tissue injury (14,41,44,52).…”
Section: Discussionsupporting
confidence: 74%
See 4 more Smart Citations
“…These results serve to confirm the emerging idea that PDE2A is a key proinflammatory enzyme that enhances the cellular and humoral inflammation associated with common forms of tissue injury (14,41,44,52).…”
Section: Discussionsupporting
confidence: 74%
“…Inhibition of eNOS, sGC, or PDE2A prevented endothelial barrier dysfunction whereas further enhancement of cGMP production with a direct sGC activator exacerbated the injury (39). More recently, an injurious role for increased lung PDE2A expression was found in a mouse model of pneumococcal pneumonia (52). Specifically, Streptococcus pneumoniae serotype-3 infection in intact mice was shown to increase PDE2A mRNA and protein at 24 h postinfection with no changes noted in mRNA for PDEs 3A, 3B, 4A, 4B, 4C, 4D, 5A, or 7A.…”
Section: Discussionmentioning
confidence: 92%
See 3 more Smart Citations